BBIO Sale Disclosure
Apuli Maricel · SEC Form 4 · Filed Nov 3, 2026
Sale
Calculated transaction value
$145.7K
Apuli Maricel Chief Accounting Officer
BBIO
BridgeBio Pharma
BBIO
Transaction date
Oct 30, 2026
Public filing date
Nov 3, 2026
Filing lag
Filed 4 days later
BBIO daily price context
Close on/before transaction
$74.95
Oct 30, 2026
First close after public filing
$77.89
Nov 4, 2026
Return after filing · so far
-4.62%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 2,000 shares @ $72.85
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001470831-26-000976
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$145.7K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Bridgebio Pharma, Inc. BBIO Current | Sale | Oct 30, 2026 | $145.7K |